✦ LIBER ✦

The ubiquitin ligase EDD mediates platinum resistance and is a target for therapy in epithelial ovarian cancer

✍ Scribed by A. Ziebarth; H. Zheng; A. Bradley; W. Sakati; S. Eier; G. Lopez-Berestein; A. Sood; S. Eblen; C. Landen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The E3 ubiquitin ligase EDD is an advers

✍ O'Brien, P M; Davies, M J; Scurry, J P; Smith, A N; Barton, C A; Henderson, M J; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 310 KB

The E3 ubiquitin ligase EDD is an advers

✍ O'Brien, P M; Davies, M J; Scurry, J P; Smith, A N; Barton, C A; Henderson, M J; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 33 KB

A KRAS variant is a biomarker of poor ou

✍ Ratner, E S; Keane, F K; Lindner, R; Tassi, R A; Paranjape, T; Glasgow, M; Nallu 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 758 KB

SERPINB3 in the chicken model of ovarian

✍ H. Kim; G. Song; W. Lim; Y. Kim; M. Kim; M. Kim; N. Park; F. Bazer; J. Han; Y. S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 411 KB